| Oryzon

Skip to main content

English
Español

Company
- Overview
- Strategy
- Team
Epigenetics
- Epigenetics
- LSD1
Programs
Patients
- Clinical Trials
Investors
News & Events
- Press releases
- Events
Contact

Search

Breadcrumb

Home

10-13 June 2021

European Hematology Association (EHA) 2021 Congress

8-9 June 2021

Precision in Drug Discovery & Preclinical Virtual Summit

1-4 June 2021

Jefferies Virtual Healthcare Conference 2021

1-4 June 2021

Oxford Global’s Online Drug Discovery Week

25-27 May 2021

Foro Medcap BME 2021

17-19 May 2021

BioEquity Europe Digital

13 May 2021

ORYZON to present new clinical data and corporate updates at international conferences in May and June

7 May 2021

ORYZON reports results and corporate update for quarter ended March 31, 2021

19 April 2021

ORYZON receives the INNOVATIVE SME seal from the Ministry of Science and Innovation

6 April 2021

ORYZON starts preclinical collaboration on autism with the Seaver Autism Center at Mount Sinai

Pagination

First page «
Previous page ‹
Page 22
Page 23
Page 24
Page 25
Current page 26
Page 27
Page 28
Page 29
Page 30
Next page ›
Last page »

Subscribe to

Company

Overview
Strategy
Team

Epigenetics

Epigenetics
LSD1

Programs

Pipeline
Iadademstat
Vafidemstat
Collaborations
Publications

Patients

Clinical Trials

Investors

Share Information
Financial Information
CNMV Filings
Analyst Coverage
Corporate Governance
Corporate Social Responsibility

News & Events

Press releases
Events

Contact

Contact
Email Alerts
Join us

© Oryzon Genomics, S.A. - All Rights Reserved

Legal
Privacy Policy
Cookie Policy
Ethics Channel